"Muscular Atrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Descriptor ID |
D009133
|
| MeSH Number(s) |
C10.597.613.612 C23.300.070.500 C23.888.592.608.612
|
| Concept/Terms |
Muscular Atrophy- Muscular Atrophy
- Atrophies, Muscular
- Atrophy, Muscular
- Muscular Atrophies
- Atrophy, Muscle
- Atrophies, Muscle
- Muscle Atrophies
- Muscle Atrophy
Neurogenic Muscular Atrophy- Neurogenic Muscular Atrophy
- Atrophies, Neurogenic Muscular
- Atrophy, Neurogenic Muscular
- Muscular Atrophies, Neurogenic
- Muscular Atrophy, Neurogenic
- Neurogenic Muscular Atrophies
- Neurotrophic Muscular Atrophy
- Atrophies, Neurotrophic Muscular
- Atrophy, Neurotrophic Muscular
- Muscular Atrophies, Neurotrophic
- Muscular Atrophy, Neurotrophic
- Neurotrophic Muscular Atrophies
|
Below are MeSH descriptors whose meaning is more general than "Muscular Atrophy".
Below are MeSH descriptors whose meaning is more specific than "Muscular Atrophy".
This graph shows the total number of publications written about "Muscular Atrophy" by people in this website by year, and whether "Muscular Atrophy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscular Atrophy" by people in Profiles.
-
Dietary protein and muscle wasting in chronic kidney disease: new insights. Curr Opin Clin Nutr Metab Care. 2023 05 01; 26(3):226-234.
-
Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? J Cachexia Sarcopenia Muscle. 2021 12; 12(6):1380-1392.
-
Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients. J Ren Nutr. 2020 07; 30(4):313-321.
-
The complex of PAMAM-OH dendrimer with Angiotensin (1-7) prevented the disuse-induced skeletal muscle atrophy in mice. Int J Nanomedicine. 2017; 12:1985-1999.
-
High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis. Oxid Med Cell Longev. 2016; 2016:9047821.
-
Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015 May; 18(3):254-62.
-
Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas. 2013 Jul; 75(3):199-206.
-
Activation of caspase-3 in the skeletal muscle during haemodialysis. Eur J Clin Invest. 2010 Oct; 40(10):903-10.
-
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 2003 Aug; 285(2):E363-71.
-
Alteration of gene expression profiles in skeletal muscle of rats exposed to microgravity during a spaceflight. J Gravit Physiol. 2002 Dec; 9(2):61-70.